Literature DB >> 24097802

Quality and consistency of clinical practice guidelines for the management of children on chronic dialysis.

Nikki J Schoenmaker1, Wilma F Tromp, Johanna H van der Lee, Martin Offringa, Jonathan C Craig, Jaap W Groothoff.   

Abstract

BACKGROUND: Clinical practice guidelines aim to improve the quality of care, yet for users of guidelines it is often not clear how these guidelines were developed and whether the recommendations are robust. We aimed to identify all current published guidelines for the management of children on chronic dialysis, assess the quality of their development and evaluate consistency among their recommendations.
METHODS: We searched Medline (1948 to January 2012), and relevant websites of guideline development programmes. Three reviewers appraised all 17 identified guidelines with the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument.
RESULTS: The guidelines were developed by five different professional associations. The overall mean AGREE II score from seven Kidney Disease Outcomes Quality Initiatives (KDOQI) guidelines was considered sufficient (mean scores 64-75%), and from all other 10 guidelines poor (29-44%). Five out of seven KDOQI guidelines scored weak on applicability. We found important inconsistencies between recommendations concerning initiation of renal replacement therapy, management of haemoglobin level and the use of mupirocin to prevent exit-site infections.
CONCLUSIONS: While the recently developed KDOQI guidelines meet the modern quality standards, advice for implementation of these recommendations is lacking. There is an urgent need for international collaboration and coordination to ensure that the management of children on chronic dialysis is informed by relevant and high-quality evidence.

Entities:  

Keywords:  dialysis; end-stage kidney disease; guidelines; paediatric nephrology; systematic review

Mesh:

Year:  2013        PMID: 24097802     DOI: 10.1093/ndt/gft303

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  End-stage renal disease in Japanese children: a nationwide survey during 2006-2011.

Authors:  Motoshi Hattori; Mayumi Sako; Tetsuji Kaneko; Akira Ashida; Akira Matsunaga; Tohru Igarashi; Noritomo Itami; Toshiyuki Ohta; Yoshimitsu Gotoh; Kenichi Satomura; Masataka Honda; Takashi Igarashi
Journal:  Clin Exp Nephrol       Date:  2015-01-17       Impact factor: 2.801

Review 2.  Guideline appraisal with AGREE II: Systematic review of the current evidence on how users handle the 2 overall assessments.

Authors:  Wiebke Hoffmann-Eßer; Ulrich Siering; Edmund A M Neugebauer; Anne Catharina Brockhaus; Ulrike Lampert; Michaela Eikermann
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

3.  Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use.

Authors:  Wiebke Hoffmann-Eßer; Ulrich Siering; Edmund A M Neugebauer; Anne Catharina Brockhaus; Natalie McGauran; Michaela Eikermann
Journal:  BMC Health Serv Res       Date:  2018-02-27       Impact factor: 2.655

4.  Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines.

Authors:  Gesine F C Weckmann; Sylvia Stracke; Annekathrin Haase; Jacob Spallek; Fabian Ludwig; Aniela Angelow; Jetske M Emmelkamp; Maria Mahner; Jean-François Chenot
Journal:  BMC Nephrol       Date:  2018-10-11       Impact factor: 2.388

5.  Neutrophil-Lymphocyte Ratio (NLR) Reflects Myocardial Inhomogeneities in Hemodialyzed Patients.

Authors:  Kamila Bołtuć; Arkadiusz Bociek; Robert Dziugieł; Martyna Bociek; Tomasz Zapolski; Wojciech Dąbrowski; Andrzej Jaroszyński
Journal:  Mediators Inflamm       Date:  2020-09-03       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.